-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNCONA shares rose 6.1% after the company announced that BEACON THERAPEUTICS had positive top-line results in the Phase II/III VISTA trial.

智通財經·09/21/2026 07:33:06
語音播報
SYNCONA shares rose 6.1% after the company announced that BEACON THERAPEUTICS had positive top-line results in the Phase II/III VISTA trial.